ASSESSING HORMONAL INFLUENCES ON TYPE 2 DIABETES IN POSTMENOPAUSAL WOMEN IN PAKISTAN: A PROSPECTIVE STUDY
Main Article Content
Keywords
.
Abstract
Background: Type 2 diabetes mellitus [T2DM] is a significant public health concern worldwide, particularly in postmenopausal women who experience hormonal changes that may increase their risk. This study aimed to assess the hormonal influences on T2DM in postmenopausal women in Pakistan and evaluate the potential benefits of hormone replacement therapy [HRT] as a preventive strategy.
Methods: A prospective cohort study was conducted at Department of Medicine, DG Khan Medical College DG khan, Pakistan, over one year from January 2023 to December 2023. A total of 128 postmenopausal women were included based on specific inclusion criteria. Participants were evaluated for their hormonal profiles, including levels of estradiol and sex hormone-binding globulin [SHBG], and their association with T2DM risk. The impact of HRT on T2DM incidence was also examined. Data were collected using standardized questionnaires and blood tests, and analyzed using appropriate statistical methods to identify significant associations.
Results: The study found that lower levels of estradiol and SHBG were significantly associated with an increased risk of T2DM in postmenopausal women [p < 0.05]. Additionally, women who received HRT had a lower incidence of T2DM compared to non-users, suggesting a protective effect of HRT. The results underscore the importance of hormonal assessment in identifying women at higher risk for T2DM and highlight the potential of targeted interventions to prevent or delay diabetes onset.
Conclusion: The findings of this study suggest that hormonal changes post-menopause significantly impact the risk of developing T2DM in Pakistani women. Monitoring hormonal levels and considering HRT as part of a comprehensive diabetes prevention strategy may be beneficial in reducing T2DM risk in this population. However, further research with larger sample sizes and diverse populations is necessary to validate these results and explore the long-term effects of hormonal therapies on diabetes prevention.
References
2. Mauvais-Jarvis F. Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab. 2011;22[1]:24-33. Available from: https://pubmed.ncbi.nlm.nih.gov/20970716/.
3. Sultan A, Meo SA, Ayoub A, et al. Type 2 diabetes mellitus in Pakistan: Current prevalence and future forecast. J Pak Med Assoc. 2016;66[1]:89-93. Available from: https://pubmed.ncbi.nlm.nih.gov/26712197/.
4. Mauvais-Jarvis F. Sex differences in metabolic homeostasis, diabetes, and obesity. Biol Sex Differ. 2015 Sep 3;6:14. doi: 10.1186/s13293-015-0033-y. PMID: 26339468; PMCID: PMC4559072.
5. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009 Sep 17;361[12]:1152-63. doi: 10.1056/NEJMoa0804381. Epub 2009 Aug 5. PMID: 19657112; PMCID: PMC2774225.
6. Kautzky-Willer A, Harreiter J, Pacini G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev. 2016 Jun;37[3]:278-316. doi: 10.1210/er.2015-1137. Epub 2016 May 9. PMID: 27159875; PMCID: PMC4890267.
7. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009 Sep 17;361[12]:1152-63. doi: 10.1056/NEJMoa0804381. Epub 2009 Aug 5. PMID: 19657112; PMCID: PMC2774225.
8. Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009 Jun;94[6]:1853-78. doi: 10.1210/jc.2008-2291. Epub 2009 Mar 31. PMID: 19336548; PMCID: PMC2690422. Available from: https://pubmed.ncbi.nlm.nih.gov/19336548/.
9. Misra A, Ganda OP. Migration and its impact on adiposity and type 2 diabetes. Nutrition. 2007 Sep;23[9]:696-708. doi: 10.1016/j.nut.2007.06.008. PMID: 17679049. https://www.sciencedirect.com/science/article/abs/pii/S0899900707001852?via%3Dihub.
10. Chiu M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care. 2011 Aug;34[8]:1741-8. doi: 10.2337/dc10-2300. Epub 2011 Jun 16. PMID: 21680722; PMCID: PMC3142051. https://diabetesjournals.org/ care/article/34/8/1741/27368/Deriving-Ethnic-Specific-BMI-Cutoff-Points-for.
11. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA. 2001 Nov 28;286[20]:2701-9. doi: 10.1001/jama.286.20.2701. PMID: 11730441. Available from: https://pubmed.ncbi.nlm.nih.gov/ 11730441/.
12. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010 Dec;33[12]. doi: 10.2337/dc10-9990. PMID: 21115758; PMCID: PMC2992225. Available from: https://pubmed.ncbi.nlm.nih.gov/21115758/.
13. Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, Jenkins AL, Axelsen M. Glycemic index: overview of implications in health and disease. Am J Clin Nutr. 2002 Jul;76[1]:266S-273S. doi: 10.1093/ajcn/76.1.266S. PMID: 12081853.